Future Ventures

Activity from announced rounds

Activity in this selectionUnited States · Oct 15, 2026 · Jul 18, 2026
Rounds participated in
4
Confirmed lead rounds
1
All roles disclosed
New companies
4
First participation on record · 0 follow-on
Funding in participating rounds
$114M
4 disclosed · full round size, not this investor’s share

By stage

Undisclosed2
Seed1
Series B1

By primary sector

Biotech2
AI1
Climate tech1

By country

United States4

Rounds

4 in this selection
Modulate

Modulate builds audio-native AI models and APIs that help developers understand voice conversations beyond their transcribed words.

$25MFunding round
Lead
Shennon Biotechnologies

Shennon Biotechnologies is developing precision T-cell engager immunotherapies for solid tumors.

$12MFunding
Participant
Moonwalk Biosciences

Moonwalk Biosciences is developing adipose-targeted siRNA medicines for obesity and cardiometabolic disease. Its lead programs are designed to alter fat-tissue pathways while limiting effects on other tissues, with the lead obesity candidate in IND-enabling development ahead of planned human testing in 2027.

$70MSeries B
Participant
Molten Salt Solutions

Lithium isotope enrichment technology for the fuel needs of advanced fission and fusion reactors.

$7MSeed
Participant